“Fides et Ratio” – 20 years – Premonitory Encyclical.

On September 14th, the Church celebrates the twentieth anniversary of the publication of the encyclical “Fides and Ratio” of Saint John Paul II.

St. John Paul II invites all men, mainly women and men of thought, to the audacious and rigorous exercise of the constitutive reason of their being, beyond their differences; in order to reach the truth.

He insists on the nobility and the decisive importance of what he indifferently calls “reason”, “philosophical reason”, “right reason”, or “philosophical-religious reason” common to all human beings.

Continue reading

Advertisements

Reflections on the human being in the face of techno-science domination

Prof. Dr. Bernard Ars, M.D., Ph.D.. FIAMC/ESPHIN http://www.arsbernard.com

1. Societal facts and definitions

Society is changing. It is not a time of change, these are actually changing times.

Techno-sciences are pervading all fields, including medicine, and are particularly affecting three main medical approaches: chemical and digital interventions on brain functions, genome modifications, as well as the use of robots.

If techno-scientific progress is to be encouraged, domination must be regulated. It in fact induces the transhumanist ideology whose challenging character lies in the anthropological rupture that it entails.

But what is this ‘transhumanism’?

Continue reading

BioEdge: Enthusiasm for gene therapy cools after animal tests

A new gene therapy technique that uses high doses of viruses to carry healthy genes to cells recently brought relief to 15 babies suffering from a lethal neuromuscular condition. As the first human trial with high-doses of the AAV9 virus, its success gave a huge boost to the gene-therapy field.

“People are going to look back and see this as a milestone in a new type of medicine that’s going to have broad implications for lots and lots of diseases,” one researcher told Science last year.

However, those hopes were chilled this week when a leading gene-therapy researcher who was involved in the successful trial also published a study in which high-dose AAV9 infusions severely affected animals. Three young rhesus macaque monkeys developed liver failure and three piglets had motor neurone damage. Some of them had to be euthanised. The cause was not immediately apparent.

Continue reading: BioEdge: Enthusiasm for gene therapy cools after animal tests